Skip navigation

Treatment of cytokine dysregulation by using sn-2 gamma-linolenoyl, gamma-dihomolinolenoyl or arachidonoyl patty acid glycerol monoesters

Treatment of cytokine dysregulation by using sn-2 gamma-linolenoyl, gamma-dihomolinolenoyl or arachidonoyl patty acid glycerol monoesters

BTG International Limited (2006) Treatment of cytokine dysregulation by using sn-2 gamma-linolenoyl, gamma-dihomolinolenoyl or arachidonoyl patty acid glycerol monoesters. WO2006/092622A1.

[img]
Preview
PDF
WO2006092622A1.pdf

Download (1MB)

Abstract

A method of treating a patient in need of therapy for a cytokine dysregulation comprising administering to that patient a therapeutically effective dose of a monoglyceride or metabolic precursor thereof of general formula (I), wherein R1 is the a fatty acyl group of an essential poyunsaturated fatty acid selected from Ϝ-linolenoyl, Ϝ-dihomolinolenoyl and arachidonoyl.

Item Type: Patent
Additional Information: Publication number WO2006092622 A1 Application number PCT/GB2006/000778
Uncontrolled Keywords: Cytokines, treatment of multiple sclerosis
Subjects: Q Science > QD Chemistry
R Medicine > RM Therapeutics. Pharmacology
Faculty / School / Research Centre / Research Group: Faculty of Education, Health & Human Sciences > School of Human Sciences (HUM)
Related URLs:
Last Modified: 09 Oct 2021 04:46
Selected for GREAT 2016: None
Selected for GREAT 2017: None
Selected for GREAT 2018: None
Selected for GREAT 2019: None
Selected for REF2021: None
URI: http://gala.gre.ac.uk/id/eprint/4328

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year

View more statistics